Merck Applications To Aid These In Want Product
Grade 5 TRAEs occurred in 1.% of patients treated with LENVIMA plus KEYTRUDA versus .eight% of individuals treated with LENVIMA monotherapy. In individuals treated with LENVIMA plus KEYTRUDA, the five most common TRAEs of any...
